Skip to content
healthcare.dev

Atracurium Besylate

NDC 71288-702, Atracurium Besylate, injection, solution, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-702
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091489
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATRACURIUM BESYLATE10 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
71288-702-107128807021010 VIAL, MULTI-DOSE in 1 CARTON (71288-702-10) / 10 mL in 1 VIAL, MULTI-DOSE (71288-702-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/efe90ee2-fe9e-421f-9e54-2961085d3b12

Use it

Look up 71288-702 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.